Literature DB >> 9344705

Low-level production of interleukin-13 in synovial fluid and tissue from patients with arthritis.

J M Woods1, G K Haines, M R Shah, G Rayan, A E Koch.   

Abstract

Rheumatoid arthritis (RA) is a chronic, aggressive disease characterized by inflammatory cells in the synovial tissue (ST) and synovial fluid (SF). Interleukin (IL)-13 inhibits the production of proinflammatory cytokines, chemokines, and hematopoietic growth factors by activated human monocytes. The aim of this study was to determine the production of IL-13 in various forms of arthritis. The presence of IL-13 in RA was found to be low, in that 18 of 26 RA SF samples and 10 of 14 RA peripheral blood (PB) samples had nondetectable levels (</=12 pg/ml). Similar low levels were found in SF and PB from patients with osteoarthritis (OA) and other arthritides. In contrast, RANTES, IL-8, monocyte chemotactic protein-1, and soluble P-selectin were found at levels of 13-, 120-, 1200-, and 2000-fold excess of IL-13, respectively. Mononuclear cells isolated from RA SFs did not produce significant levels of IL-13 in culture (</=12 pg/ml) but were able to do so when stimulated with phytohemagglutinin. Likewise, tissue explants from RA synovium cultured for 24 or 48 hr with or without serum did not produce appreciable quantities of IL-13 (</=12 pg/ml). Immunohistochemical data were in accordance with this result in that antigenic IL-13 was not detected on the majority of RA, OA, and normal (NL) ST cells. These results demonstrate a paucity of IL-13 within the joints of RA, OA, NL, and other arthritic patients by comparison with levels of other cytokines. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344705     DOI: 10.1006/clin.1997.4441

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  7 in total

1.  Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.

Authors:  A K Ulfgren; L Gröndal; S Lindblad; M Khademi; O Johnell; L Klareskog; U Andersson
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

Review 2.  Osteoarthritis and cartilage: the role of cytokines.

Authors:  M B Goldring
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

3.  Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation.

Authors:  Daniela Cihakova; Jobert G Barin; Marina Afanasyeva; Miho Kimura; DeLisa Fairweather; Michael Berg; Monica V Talor; G Christian Baldeviano; Sylvia Frisancho; Kathleen Gabrielson; Djahida Bedja; Noel R Rose
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

4.  Cytokine mRNA and protein expression in primary-culture and repeated-passage synovial fibroblasts from patients with rheumatoid arthritis.

Authors:  Astrid Hirth; Alla Skapenko; Raimund W Kinne; Frank Emmrich; Hendrik Schulze-Koops; Ulrich Sack
Journal:  Arthritis Res       Date:  2001-11-08

Review 5.  Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis.

Authors:  Milena Iwaszko; Sylwia Biały; Katarzyna Bogunia-Kubik
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

6.  The Relationship of Cytokines IL-13 and IL-17 with Autoantibodies Profile in Early Rheumatoid Arthritis.

Authors:  Isabela Siloşi; Mihail Virgil Boldeanu; Manole Cojocaru; Viorel Biciuşcă; Vlad Pădureanu; Maria Bogdan; Ramona Georgiana Badea; Carmen Avramescu; Ileana Octavia Petrescu; Florin Petrescu; Cristian A Siloşi
Journal:  J Immunol Res       Date:  2016-08-04       Impact factor: 4.818

7.  IL13Rα1 protects against rheumatoid arthritis by combating the apoptotic resistance of fibroblast-like synoviocytes.

Authors:  Xiaomei Yang; Qingwei Guo; Tingting Feng; Qiqi Lu; Luna Ge; Jihong Pan; Kehong Bi; Li Qiao; Lei Tian; Tianhua Xie; Chengfang Yao; Guanhua Song; Lin Wang
Journal:  Arthritis Res Ther       Date:  2020-08-08       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.